Skip to main content

Anti‐bacterial and wound healing‐promoting effects of zinc ferrite nanoparticles

Abstract

Background

Increasing antibiotic resistance continues to focus on research into the discovery of novel antimicrobial agents. Due to its antimicrobial and wound healing-promoting activity, metal nanoparticles have attracted attention for dermatological applications. This study is designed to investigate the scope and bactericidal potential of zinc ferrite nanoparticles (ZnFe2O4 NPs), and the mechanism of anti-bacterial action along with cytocompatibility, hemocompatibility, and wound healing properties.

Results

ZnFe2O4 NPs were synthesized via a modified co-precipitation method. Structure, size, morphology, and elemental compositions of ZnFe2O4 NPs were analyzed using X-ray diffraction pattern, Fourier transform infrared spectroscopy, and field emission scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy. In PrestoBlue and live/dead assays, ZnFe2O4 NPs exhibited dose-dependent cytotoxic effects on human dermal fibroblasts. In addition, the hemocompatibility assay revealed that the NPs do not significantly rupture red blood cells up to a dose of 1000 µg/mL. Bacterial live/dead imaging and zone of inhibition analysis demonstrated that ZnFe2O4 NPs showed dose-dependent bactericidal activities in various strains of Gram-negative and Gram-positive bacteria. Interestingly, NPs showed antimicrobial activity through multiple mechanisms, such as cell membrane damage, protein leakage, and reactive oxygen species generation, and were more effective against gram-positive bacteria. Furthermore, in vitro scratch assay revealed that ZnFe2O4 NPs improved cell migration and proliferation of cells, with noticeable shrinkage of the artificial wound model.

Conclusions

This study indicated that ZnFe2O4 NPs have the potential to be used as a future antimicrobial and wound healing drug.

Background

Since the accidental discovery of penicillin, antibiotics have been used to treat infectious diseases, which has significantly increased life expectancy and reduced mortality. However, due to excessive use and mismanagement of antibiotics, microorganisms develop resistance to a variety of traditional antibiotics over time, presenting major health problems for future infectious disease management [1, 2]. Recently, deaths associated with bacterial infection are increasing, due to the limited efficacy of existing antibiotics against certain microorganisms, such as methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus Pneumoniae, and carbapenem-resistant Enterobacteriaceae. Therefore, new antibiotic treatment strategies are needed that can effectively treat bacterial infections that are resistant to existing antibiotics [3].

Burn wounds are the most lethal form of trauma that requires infection control to reduce morbidity and mortality [4]. Severe thermal damage results in damage to the skin’s superficial barrier as well as an immunosuppressive state, making burn patients vulnerable to infectious complications [5]. According to the previous clinical studies, 42–65 % of deaths amongst burn patients are due to infections [6]. The resistance of burn wound-related pathogens such as Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) to local and systemic anti-infective agents is making treatment more difficult [7]. Therefore, for the management of burn wound infection, new antimicrobial agents that are effective against antibiotic-resistant bacteria, non-toxic to normal cells, cost-effective, and do not cause bacterial resistance are needed.

The use of inorganic nanoparticles particularly metal nanoparticles (MNPs) and their oxides (e.g., ZnO [8], AgO [9], CuO [10], and CoO [11] NPs) has gained significant attention because of their promising results in targeted drug delivery [12], medical imaging [13], cancer treatment [14, 15], and inhibiting bacterial growth [16, 17] as well as promoting wound healing potential [18]. Furthermore, MNPs are desirable in fungicidal [19], and antimicrobial pharmaceuticals due to their durability, high stability, and low mammalian cell toxicity compared to organic NPs. Their nanoscale size and variable surface chemistry allow them to induce bacterial toxicity through several modes of actions such as, lipid peroxidation, oxidative stress, cell membrane lysis, enzyme inhibition, and proteolysis [17, 20, 21].

Among different MNPs, iron oxide-based NPs, especially spinel ferrites, have recently emerged as popular candidates for emerging biomedical applications due to their chemical stability, biocompatibility, the reasonable cost compared to the other MNPs such as silver NPs (i.e., gold standard anti-bacterial NPs), and their unique ferromagnetic properties [22, 23]. Spinel ferrites are homogenous materials consisting primarily of iron and have a general chemical formula of MFe2O4, in which M2+ and Fe3+ respectively reside in tetrahedral and octahedral metallic cation spots of the lattice [22]. The minuscule dimension of spinel ferrite NPs makes them an ideal candidate in a broad spectrum of biological applications, including their use as contrast agents in magnetic resonance imaging (MRI) [24], targeted drug delivery, and magnetic hyperthermia [25]. Among spinel ferrites, ZnFe2O4 NPs have gained attention in various biomedical applications due to their bio-friendly character, lower toxicity than other metal ferrites, chemical stability, easy and reproducible synthesis, low saturation magnetization, and photo-induced catalytic reactant properties [26, 27].

Owing to many advantages in biomedical applications, it is worth exploring the wound healing potential of ZnFe2O4 NPs and thoroughly investigate their anti-bacterial efficacy and mechanism of action in burn wound bactericidal effect. In this study, we fabricated ZnFe2O4 NPs using the co-precipitation process. The co-precipitation method is one of the most convenient, eco-friendly, and economical methods of synthesis, yielding NPs with high purity [28]. However, adequate control is needed to monitor the size, stoichiometry, phase purity, and crystallinity of the NPs [29], which could be controlled in this study by tuning the reaction’s parameters. We further characterized the structure, morphology, and size of the synthesized ZnFe2O4 NPs using different physicochemical techniques, and also investigated their cytocompatibility and hemocompatibility in a dose-dependent manner. Moreover, we studied the dose-dependent antimicrobial activity of ZnFe2O4 NPs against selected Gram-positive and Gram-negative microbial strains as possible infection models, exploring the antimicrobial mode of action via different techniques. In addition, by performing a scratch assay, we could further demonstrate the in vitro wound healing potential of ZnFe2O4 NPs. We anticipate that this research will offer solid grounds to use ZnFe2O4 NPs as a potential source to control bacterial infections in a cost-effective manner, as well as improve the wound healing process.

Materials and methods

Chemicals and reagents

Zinc chloride (ZnCl2), iron chloride hexahydrate (FeCl3.6H2O), sodium hydroxide (NaOH), oleic acid, and nutrient agar were purchased from Daejung Korea (Nakdong-daero, Sasang-gu, Busan, Korea). Dulbecco’s Modified Eagle’s Medium (DMEM containing L-Glutamine and 4.5 g/L Glucose), fetal bovine serum (FBS), 100X Penicillin-Streptomycin (Pen/Strep), 0.25 % trypsin-EDTA, silver sulfadiazine, tetracycline hydrochloride, dimethyl sulfoxide (DMSO), Drabkin’s reagent, pure human hemoglobin and bovine serum albumin (BSA) were bought from Sigma-Aldrich (Saint Louis, MO, USA). Bacto tryptic soy broth, Difco Agar, Lb Agar, Live/dead viability/cytotoxicity kit, PrestoBlue dye, polyethylene glycol (PEG), live/dead BacLight bacterial viability kit, and fluorescein isothiocyanate fluorescent dye (FITC) were obtained from Fisher Scientific (Waltham, MA, USA). Tetracycline, Bio-Rad Protein reagent, and dichlorofluorescein diacetate (DCFDA) dye were acquired from Bio-Rad Laboratories (Hercules, CA, USA). NIH-3T3 murine fibroblast, human dermal fibroblast (HDF) cells, and bacterial cultures were provided by American Type Culture Collection (ATCC, Manassas, VA, USA).

Synthesis of zinc ferrite nanoparticles (ZnFe2O4 NPs)

ZnFe2O4 NPs were synthesized via a previously described co-precipitation method with minor modifications [30]. An aqueous solution of iron and zinc chloride was prepared in a fixed 1:2 molar ratio mixture of Zn/Fe. Oleic acid (2 drops in every 75 mL of reaction) was added to the solution as a surfactant. Under constant magnetic stirring, sodium hydroxide (NaOH) solution (3 M) was added dropwise (2 mL/min) until the pH changed to alkaline (> 12). The reaction temperature was maintained at 80 °C during the whole process. After achieving the required level of pH, precipitates were collected via centrifugation (6000 rpm, 5 min) and washed thoroughly with distilled water and 70 % ethanol until the pH turned neutral. After washing, particles were dried at 80 °C to obtain a powder, and finally annealed at 500 °C.

Characterization of ZnFe2O4 NPs

The X-ray diffraction (XRD, Bruker, D8 Advanced, Madison, Wisconsin, USA) analysis at the scan rate of 1.2°/min and the 2θ range of 20°–80° was carried out. Cu Kα (λ = 1.54056 Å) was used as a radiation source and generated at 40 kV and 40 Ma. The crystallite size was measured using the Debye Scherrer formula [31, 32]. Fourier transform infrared spectroscopy (FTIR) was performed to determine the stretching and bending vibrations of various bonds or functional groups in organic or inorganic materials. FTIR spectra in a range of 400–4000 cm− 1 were recorded using the FTIR spectrometer (JASCO FTIR-6600). Field emission scanning electron microscopy (FE-SEM, TESCAN, MIRA3, Institute of Space Technology, ISB) equipped with energy-dispersive X-ray spectroscopy (EDX), was conducted to assess the surface morphology and elemental compositions of ZnFe2O4 NPs. For this purpose, dried powder of ZnFe2O4 NPs was sprinkled on double-sided carbon-coated tape, followed by gold sputtering, to improve conductivity during imaging. FE-SEM images were captured under an acceleration voltage of 20 kV.

Cytocompatibility study

A cytocompatibility study was performed according to the previously reported literature to check the toxicity of ZnFe2O4 NPs [33]. For this purpose, HDF cells were cultured in DMEM, containing 10 % FBS and 1 % Pen/Strep antibiotics, and incubated in a standard environment of 5 % CO2 and 37 ºC. To evaluate metabolic activity of the cells, the PrestoBlue assay was carried out according to the manufacturer’s protocol. The HDFs (5000 cells/mL) were seeded in a 48-well plate and allowed to attach for 24 h. Subsequently, experimental concentrations of ZnFe2O4 NPs (62, 125, 250, 500, and 1000 µg/mL) were prepared in cell culture media (DMEM) and sonicated for 30 min until completely dispersed. In the concentration range we tested (< 1000ug/mL), the nanoparticles were completely dispersed in the medium and did not precipitate over time. The dispersed NPs were applied to the cells and incubated for 5 days. The PrestoBlue assay was conducted on Day 1 and 5 of the treatment, and fluorescence intensity was quantified using a microplate reader (excitation/emission wavelengths of ~ 530/590 nm, BioTek UV/VIS synergy 2, USA). To monitor cell viability of HDF cells, live/dead assay was performed on day 5 of NPs treatment. The cells were incubated for 20 min with staining solution (1 mL), composed of ethidium homodimer-1 (20 µL) and calcein-AM (5 µL) in DPBS (10 mL). Sample pictures were acquired using an inverted fluorescence microscope (Axio Observer 5, Zeiss, Germany) at excitation/emission wavelengths of 528/617 nm and 494/515 nm for ethidium homodimer-1 and calcein, respectively.

In vitro hemolysis assay

Hemolytic activity of ZnFe2O4 NPs at different concentrations (62, 125, 250, 500, and 1000 µg/mL in DPBS) was evaluated following the Standard Practice for Assessment of Hemolytic Properties of Materials from American Society for Testing and Materials (ASTM E2524-08 guideline (2013)) [34]. Briefly, heparinized fresh human blood was diluted to adjust the hemoglobin level ~ 10 mg/mL. The concentration of hemoglobin was measured by Drabkin’s reagent, using a standard curve generated from the known concentrations of pure human hemoglobin. Subsequently, the experimental concentrations of NPs were added to 800 µL DPBS in Eppendorf tubes and gently mixed with 100 µL of the diluted blood. Triton X-100 (1 % v/v in DPBS) and PEG (4.4 % v/v in DPBS) were used as positive control (PC) and negative control (NC), respectively. The samples were placed at 37 °C water bath for ~ 3 h and then centrifuged (14,000 rpm, 15 min) at room temperature. The supernatant (100 µL) was added to 100 µL Drabkin’s reagent in a 96-well plate, and was shaken gently for 15 min, in the dark. The absorbance at 540 nm was measured using a microplate reader. Percent hemolysis was assessed using the below equation:

$${\text{Hemolysis} (\% ) = \text{(Hemoglobin\,concentration in sample/Total diluted blood hemoglobin)}} \times {{100}}$$

Antimicrobial test

The antimicrobial activity of ZnFe2O4 NPs was performed following a standard agar well diffusion method, with minor modifications [35]. The bacteria selection was made according to the prevalence at burn wound infection site [36, 37]. Selected concentrations of ZnFe2O4 NPs for antimicrobial activity were 12.5, 25, 50, and 100 µg/mL. Firstly, an inoculum of selected microorganisms was added in autoclaved nutrient broth, and optical density (OD) was maintained between 0.1 and 0.5 at 600 nm, using nanodrop (OneC Microvolume UV-Vis Spectrophotometer, Thermo Scientific, USA) similar to that explained elsewhere [38,39,40,41]. This inoculum was evenly spread on agar plates. Wells (8 mm in diameter) were bored on an inoculated agar plate, and the NPs solution (100 µL) was poured into the well and incubated at 37 °C for 12 h. Sterilized 8 mm filter paper disk loaded with silver sulfadiazine cream (15 µg/disk) was placed on plates, which acted as a positive control, and DMSO was poured in one well as vehicle control. The zone of inhibition was evaluated after 24 h.

The antimicrobial activity of ZnFe2O4 NPs was further confirmed by live/dead bacterial viability kit using one representative Gram-negative bacteria (E. coli) and one Gram-positive bacteria (S. aureus), respectively. Only one representative concentration (100 µg/mL) of ZnFe2O4 NPs was tested, as this concentration was the highest dose to exhibit no toxicity when tested with human cells. The live/dead assay was performed following a previously reported protocol [42]. The E. coli and S. aureus cultures were grown overnight until log phase was reached and a concentration of 1 × 105 CFU/mL was ensured. The selected concentration (100 µg/mL) of ZnFe2O4 NPs were added to the bacterial strains and incubated at 37 °C for 8 h. Bacterial strains incubated with tetracycline were considered as a positive control. Following incubation, bacteria were collected via centrifugation (10,000 rpm, 5 min, 4 °C). Resultant pallets were washed with DPBS and stained for 15 min under a dark condition with SYTO9 and propidium iodide (PI). A fluorescence microscope captured fluorescence images of the stained bacteria at an excitation wavelength of 540–580 nm and an emission of 600–660 nm for PI. The excitation wavelength of 465–495 nm, and emission of 515–555 nm were used for SYTO9.

Membrane permeability assay

The membrane permeability assay was conducted following the reported protocol [43]. During the exponential phase, bacteria (E. coli and S. aureus) were cultured and incubated for 12 h with a concentration of 100 µg/mL ZnFe2O4 NPs in LB growth medium, containing FITC dye (0.05 % w/v). Tetracycline (5 mg/mL) treated bacteria served as a positive control. Excessive FITC dye was removed from the media by several autoclaved distilled water washings and centrifugations. Finally, photographs of the bacteria were taken with a fluorescence microscope at excitation/emission wavelengths of ~ 491/516 nm.

Protein leakage assay

To check the effect of ZnFe2O4 NPs treatment on bacterial cell protein leakage, Bio-Rad protein assay was performed following the reported protocol [44]. For this assay, the fresh tryptic soy broth (TSB; Bacto; 5 mL) cultures of E. coli and S. aureus, were washed with normal saline through centrifugation (10,000 rpm, 15 min). Resultant pellets were suspended in normal saline and treated with 100 µg/mL of ZnFe2O4 NPs for 8 h at 37 °C. Afterward, bacterial suspension was centrifuged (12,000 rpm, 15 min), and the acquired supernatant was used for protein content estimation via the Bio-Rad protein assay kit, which relies on the Bradford principle. Protein concentration was measured in ZnFe2O4 NPs treated samples from the standard curve established by known amounts of bovine serum albumin (BSA) and compared with untreated bacteria (control).

Reactive oxygen species (ROS) measurement

The level of ROS produced in bacteria after treatment with NPs was measured using the previously reported DCFDA dye method [45]. Initially, E. coli and S. aureus were incubated with 100 µg/mL ZnFe2O4 NPs for 8 h and then centrifuged for 5 min at 9000 rpm. Resultant pellets were resuspended in DCFDA dye (30 µg/mL in DPBS) and incubated in dark condition for 30 min at 37 ºC. Subsequently, centrifugation was carried out, and the pellet was resuspended in DPBS. Further, fluorescence intensity was quantified at excitation/emission wavelengths of 485/528 nm using a microplate reader.

In vitro scratch assay

The in vitro scratch assay of ZnFe2O4 NPs was conducted according to the previously reported protocol [46]. For this purpose, NIH-3T3 fibroblasts (1 × 106 cell/mL) were seeded with complete DMEM media in a 6-well plate and incubated at standard conditions. As soon as the cell growth reached the uniform monolayer, a scratch was made with a sterilized pipette tip, followed by cell washing with DMEM (without FBS) to remove excess detached cells. Subsequently, the sterilized ZnFe2O4 NPs (100 µg/mL in FBS-free DMEM) were added to the cells. In the control group, cells were remained untreated. After 0, 18, and 36 h of treatment, images were taken with bright field microscopy (Axio Observer 5, Zeiss, Germany). Furthermore, the initial and final width of the scratch were measured with ImageJ software (version 1.52e). The scratch shrinkage percentage was calculated with the following formula:

Scratch shrinkage (%) = (Original width – Final width) × 100/Original width.

Statistical analysis

All data were taken in triplicate, and the mean ± standard deviation (SD) was measured via GraphPad Prism (version 7.03). One-way ANOVA, followed by Tukey’s multiple comparisons test, was used to analyze the data for all the experiments except PrestoBlue and scratch assay’s results which were analyzed with Two-way ANOVA and t-test, respectively. P-value ≤ 0.05 was considered statistically significant.

Results and discussion

Analyses of crystal structure and FTIR spectrum of ZnFe2O4 NPs

First, we fabricated ZnFe2O4 NPs using co-precipitation process. The co-precipitation method is one of the most convenient, eco-friendly and economical methods of synthesis, yielding NPs with high purity [28]. However, adequate control is needed to monitor the size, stoichiometry, phase purity, and crystallinity of the NPs [29], which could be controlled in this study by tuning the reaction’s parameters. Since the crystalline phase and crystallite size of the NPs are the parameters that influence on their biological activity and properties [47], we analyzed crystal structure and phase formation of ZnFe2O4 NPs, via XRD spectrum. The XRD analysis is important because it provides information regarding the crystalline structure, nature of the phase, lattice parameters, and crystalline grain size of NPs [48]. As shown in Fig. 1a, the XRD diffraction patterns confirmed synthesis of pure phase and crystalline spinel ferrite NPs. The well-resolved peaks corresponded to the (220), (311), (400), (422), (511), and (440) planes of ZnFe2O4 (JCPDS: 001-1109), suggesting the successful synthesis of ZnFe2O4 NPs. These findings are in agreement with previously reported results [49, 50]. The average crystallite size calculated via the Scherer formula was ~ 46 nm. In addition to XRD analysis, we further analyzed the formation of the spinel structure of zinc ferrite and its cation distribution was explored by FTIR analysis [51]. FTIR spectrum of ZnFe2O4 NPs was recorded in the range of 400–4000 cm− 1, as shown in Fig. 1b. The inset of Fig. 1b clearly shows that all the peaks present in the range of 400–600 cm− 1, confirming that the capping agent/surfactant used during the synthesis did not bind with ZnFe2O4 NPs. The absorption band at 460 cm− 1 represents the intrinsic metal-oxygen stretching vibration located at the octahedral sublattice (Fe) site. Another absorption band at ~ 500 cm− 1 was assigned to metal-oxygen vibration in tetrahedral lattice (M) sites. The observed bands’ positions for ZnFe2O4 NPs are in agreement with the characteristic vibration bands of spinel nano ferrite [52, 53].

Fig. 1
figure1

a X-ray diffraction (XRD) patterns, b Fourier-transform infrared spectroscopy (FTIR) spectrum of the synthesized zinc ferrite (ZnFe2O4) NPs

Surface morphology and chemical compositions of ZnFe2O4 NPs

The very small size of spinel ferrites allows them to easily cross the tiny pores of a bacterial cell wall, resulting in a bactericidal effect. The antibacterial activity of spinal ferrites is accredited to the cation attraction by the protein in the bacterial cell wall which leads to the formation of insoluble metal proteinate and associated bacterial death [54]. Among various physico-chemical properties, the size, shape and surface charge of the NPs can affect their internalization and biological activity [55], such as anti-bacterial potential. For example, NPs with a smooth surface have a more chance to contact with a bacterial cell wall [56]. Also, spherical NPs with a smaller size indicates increased anti-bacterial activity compared to the spherical NPs with a larger size due to having a higher surface area [57]. Therefore, we elucidated surface morphology and size of the synthesized ZnFe2O4 NPs using the FE-SEM technique. Figure 2 presents the FE-SEM micrograph of ZnFe2O4 NPs with the EDX spectrum. FE-SEM image showed that most of the particles are spherical in shape and smooth on the surface (Fig. 2a). The particles displayed little agglomeration, with an average particle size of 47.9 ± 2.5 nm. The average size estimated by microscopy was in agreement with our XRD data. Figure 2b exhibits the obtained peaks in the EDX spectrum corresponded to oxygen (O), iron (Fe), and zinc (Zn) elements, as expected. The measured weight % were as follows: O (24.63 %), Fe (48.13 %), and Zn (27.24 %). No additional FTIR peaks were observed, suggesting that the synthesized NPs were devoid of impurities. In addition, these results were in line with those of the previously published ZnFe2O4 NPs [58].

Fig. 2
figure2

a Field-emission scanning electron microscopy (FE-SEM) image of zinc ferrite nanoparticles (ZnFe2O4 NPs) exhibits spherical particles with an average size of 47.9 ± 2.5 nm. b Energy-dispersive X-ray spectroscopy (EDX) spectrum of ZnFe2O4 NPs shows the elemental compositions reflecting with the determined weight percentage and atomic percentage of all elements (i.e., zinc, Zn; iron, Fe; and oxygen, O) according to stoichiometry

Dose‐dependent cytotoxicity effect of NPs

Despite the growing role of NPs in drug delivery and as therapeutic solutions, their medical use is often limited due to toxicity concerns [59]. Therefore, it is important to analyze its biocompatibility with human cells to confirm possible toxicity of ZnFe2O4 NPs. According to Iacovita et al., ZnFe2O4 NPs synthesized using polyol mediated procedure (~ 12 nm in size) were biocompatible to human retinal pigment epithelial cells (D407) at the dosage of 100 µg/mL, with reflected viability of 91 %; however by increasing the concentration to 200 µg/mL, cell viability reduced to 50 % [60]. In this study, we evaluated the cytotoxicity of ZnFe2O4 NP through two methods, a live/dead viability assay that can analyze the live/dead status according to the integrity of the plasma membrane of a cell, and a PrestoBlue assay that can analyze mitochondrial activity. The live/dead viability assay showed that ZnFe2O4 NPs exhibited dose-dependent toxicity to the HDF cells. At low NPs concentrations (0 µg/mL to 250 µg/mL), no cytotoxic effects were observed in the HDF cells and majority of the cells were green in color (Fig. 3a–d) similar to the control (Fig. 3a), whereas at 500 µg/mL (Fig. 3e) and 1000 µg/mL (Fig. 3f), high numbers of red fluorescence were observed, denoting significant cell death. Through the live/dead assay we were able to observe numerous live cells at doses of ≤ 125 µg/mL, but to confirm that the live cells are not in a state of inhibition of cell proliferation, we further performed the PrestoBlue assay. Similar to the live/dead viability assay, at high NP concentrations of 500 and 1000 µg/mL, the metabolic activity of cells was significantly reduced by 80 % and 95 %, respectively (Fig. 3g). On the other hand, the metabolic activity of 62, 125, and 250 µg/mL of ZnFe2O4 NPs remained at 96 %, 92 %, and 84 % respectively on day 5 of treatment. Based on these results, we confirmed that a safe dose of ZnFe2O4 NP for HDF cells was less than 125 µg/mL, as at this concentration more than 90 % of the cells were viable and metabolically active.

Fig. 3
figure3

In vitro biocompatibility assay. Representative fluorescence microscopy images of human dermal fibroblast cells (HDF) stained with ethidium homodimer-1 (red color; dead cells) and calcein-AM (green color; live cells) after 5 days incubation with ZnFe2O4 NPs at concentrations of a 0 µg/mL (control), b 62 µg/mL, c 125 µg/mL, d 250 µg/mL, e 500 µg/mL, and f 1000 µg/mL. Scale bars show 500 µm. g The percent (%) metabolic activity of HDF cells on day 1 and 5 after subjecting to different concentrations of ZnFe2O4 NPs. Error bars denote the standard deviations of 4 replicates, and * represents the significance of the reduction in % metabolic activities of treated cells as compared to control. The data were analyzed by two-way ANOVA, and *p  0.05, ****p  0.001 were considered statistically significant

The possible mechanisms effecting on cytotoxicity of the MNPs by cells include size, size distribution, shape, surface charge, and route of synthesis [61, 62]. For example, plant-mediated synthesized spherical AgNPs with a size range of 25–40 nm were non-toxic to HCT-116 human colon cancer cells even at the higher dosage of 350 µg/mL, whereas, Algae-mediated synthesized spherical AgNPs with average size of ~ 31 nm cytotoxic against HT-29 colorectal cancer cells [63], demonstrating the effect of synthetic route on toxicity of the NPs. Moreover, the meta study on MNPs revealed that the NPs with the size below 25 nm are more toxic than those with the size range of 25–50 nm against both cancer and normal cells [55].

Hemocompatibility of NPs with red blood cells

Along with cytotoxicity testing, we further analyzed the effect of ZnFe2O4 NPs on human red blood cells. NPs are reported to cause persistent biochemical and morphological changes (erythrocyte membrane rupture) that significantly affect red blood cell function and lead to hemolysis [64, 65]. According to earlier studies on iron oxide NPs, it was found that Fe2O3 NPs induced 75 % hemolysis at 600 µg/mL and 12.48 % hemolysis at 12.5 µg/mL [66]. Therefore, it is worthwhile to explore the hemocompatibility of ZnFe2O4 NPs before using them in biomedical applications. The hemolytic activity of ZnFe2O4 NPs was investigated at different concentrations (62, 125, 250, 500, and 1000 µg/mL). As shown in Fig. 4a, the positive control (i.e., Triton X-100) contained hemoglobin that the color of the supernatant was changed to pink to red color. Interestingly, no hemoglobin was released in the supernatant of the NPs-treated samples and the negative control (i.e., PEG). Quantitative data analysis of free hemoglobin showed no significant hemoglobin release compared to the positive control in NP-treated samples. However, at the concentrations of 500 and 1000 µg/mL, which showed cytotoxicity, slight hemolysis was observed compared to the negative control as shown in Fig. 4b. The amount of hemolysis induced by ZnFe2O4 NPs was 4.7 % at the highest dose of 1000 µg/mL, which was lower than the allowable tolerance (i.e. 5 %) of the ASTM F756-08 guideline [13]. In addition, our results are in line with the hemolysis results of ZnFe2O4 NPs reported by Martínez et al. 2019 that ZnFe2O4 NPs do not cause hemolysis at 200 µg/mL [67]. Our results demonstrate that the addition of a transition metal (zinc) to an iron oxide formulation can significantly improve the hemocompatibility. Based on the cytocompatibility and hemocompatibility results, we used a ZnFe2O4 NP concentration of less than 125 µg/mL, which did not affect cell viability, in subsequent experiments.

Fig. 4
figure4

Hemocompatibility of zinc ferrite nanoparticles (ZnFe2O4 NPs). a Photographs of hemolysis assay to detect the presence of hemoglobin in the supernatant of ZnFe2O4 NPs treated samples. b Hemolysis percentage of ZnFe2O4 NPs treated samples versus positive and negative control. PEG and Triton X-100 lysed blood cells served as a negative control (NC) and positive control (PC), respectively. The values presented in the graph are mean ± SD of triplicate and *p  0.05, ****p  0.0001 were considered statistically significant

Bacterial growth inhibition by ZnFe2O4 NPs

To verify the antimicrobial effects of ZnFe2O4 NPs, different concentrations (12.5, 25, 50, and 100 µg/mL) of NPs were applied to four Gram-negative (E. coli, P. aeruginosa, S. typhi, and K. pneumoniae) and two Gram-positive (S. aureus and MRSA) microbial species which are the most prevalent source of the burn wound infection [36, 37]. In the zone of inhibition analysis test, the higher the sensitivity of the bacterial strain to the anti-bacterial material, the larger the diameter of the bacterial inhibition zone. The representative image of zone of inhibition for S. aureus strain is shown in Fig. 5 and the average zone of inhibition for each strain is summarized in Table 1. Our results showed that vehicle control (DMSO) did not inhibit the growth of the bacteria, whereas positive control (1 % silver sulfadiazine cream) exhibited a larger zone of inhibition compared to ZnFe2O4 NPs treated samples (up to 100 µg/mL of NPs). ZnFe2O4 NPs showed clear growth inhibitory effects against both Gram-negative and Gram-positive microorganisms in the experimental concentration range (12.5–100 µg/mL). The maximum zone of inhibition was produced against the S. aureus (13 ± 0.9 mm) and K. pneumoniae (13 ± 1.6 mm) at a concentration of 100 µg/mL NPs. Interestingly, although the maximum amount of ZnFe2O4 NP used in this experiment was 100 times less than that of the commercially available silver sulfadiazine cream, it showed 68.2–75.9 % bacterial growth inhibitory effects compared to silver sulfadiazine cream. Madhukara et al. demonstrated that ZnFe2O4 NPs exhibit efficient antimicrobial activity against foodborne pathogens [68]. Similar to our findings, anti-bacterial activity was had previously been reported for ZnFe2O4 NPs, but only for a single dose (600 µg/mL) [69]. The higher susceptibility of the Gram-positive bacteria to the NPs can be due to the lower stiffness of the cell wall compared to the Gram-negative E.coli, which has a complex outer membrane [70]. Another possible reason can be the size, shape, and surface charge of the ZnFe2O4 NPs, which could render them more favorable to interact with Gram-positive bacteria, which should be studied in the future.

Fig. 5
figure5

Bacterial growth inhibition of zinc ferrite nanoparticles (ZnFe2O4 NPs). Representative zone of inhibition images after treatment of S. aureus bacteria with different concentrations of ZnFe2O4 NPs (12.5–100 µg/mL) compared to the vehicle control (DMSO) and positive control (1 % silver sulfadiazine cream)

Table 1 Estimated zone of inhibition after treatment of pathogenic bacteria with different concentrations of ZnFe2O4 NPs

Taking one step further from analyzing bacteriostatic effect of ZnFe2O4 NPs, the bactericidal effect of NPs was analyzed by live/dead assay. For this assay, one representative Gram-negative bacteria (E. coli) and one Gram-positive (S. aureus) were selected. SYTO 9, a green fluorescent dye, adheres to healthy living bacterial cells, and PI combines with dead and damaged cells to emit red fluorescence, allowing the evaluation of bacterial death [71]. As shown in Fig. 6, significant bacterial killing was not observed in the E. coli and S. aureus negative controls (Fig. 6a, b), while most of the bacteria were killed in the positive control treated with 60 µg/mL of tetracycline (Fig. 6c, d). As shown in Fig. 6e and f, E. coli and S. aureus cells treated with NPs (100 µg/mL) also showed numerous dead cells, emitting red fluorescence. The bactericidal efficacy by NPs was not only significantly higher than the untreated negative control, but was high enough to correspond to the positive control. Quantitative results show that ZnFe2O4 NP treatment caused 71 % and 85 % of bactericidal effect in E. coli and S. aureus, respectively (Fig. 6g). The bactericidal efficacy of ZnFe2O4 NPs was as good as tetracycline and significantly higher than the untreated negative control. The Gram-positive bacteria, S. aureus was more susceptible to NPs treatment compared to Gram-negative E. coli similar to bacteriostatic results. These findings are in line with previously reported literature indicating that ZnFe2O4 NPs possess broad-spectrum antimicrobial properties [72, 73]. It has been reported that ZnFe2O4 NPs can efficiently kill E. coli and S. aureus at 5 mg/mL doses [73]. However, as can be seen in our cytocompatibility study (toxic at > 200 µg/mL), this reported dose is quite high and may be toxic to mammalian cells as well. In this study, we were able to show that ZnFe2O4 NPs synthesized by the co-precipitation method showed higher antibacterial activity, which could kill bacteria at a much lower dose (i.e., 100 µg/mL) than other NP synthesis methods.

Fig. 6
figure6

Bacterial live/dead assay. Fluorescence micrographs of E. coli and S. aureus after treatment with 100 µg/mL of ZnFe2O4 NPs. a Negative control E. coli cells without any treatment. b S. aureus negative control without treatment. c E. coli treated with tetracycline (positive control). d S. aureus treated with tetracycline (positive control). e E. coli treated with ZnFe2O4 NPs (100 µg/mL). f S. aureus treated with ZnFe2O4 NPs (100 µg/mL). g Percent (%) dead cells of E. coli and S. aureus after ZnFe2O4 NPs treatment as compared to the negative control (NC) and positive control (PC). Experiments were performed in triplicate. The percent dead cells of E. coli and S. aureus were significantly higher in nanoparticle-treated groups and positive control as compared to the negative control. *p ≤ 0.05 and ****p ≤ 0.0001 are statistically significant. Scale bars show 200 µm

Effects of NPs on bacterial cell membrane permeability

Along with the bacteriostatic and bactericidal effect results, we further explored the effect of NPs on membrane permeability as one of the mechanisms involved in bacterial death. Bacterial cell membrane behaves as a chemical compartment, helping to retain cellular hemostasis, acting as a barrier, and providing selective permeability to the cell, thus playing a significant role in diverse physiological functions. Any disruption in bacterial cell membrane structure adversely affects its function, potentially leading to death [74, 75]. Bacterial cells are generally impermeable to the fluorescent dye FITC, but if their membrane is disrupted by the anti-microbial agent, FITC can quickly penetrate the bacteria and render them fluorescent green. As expected, the negative control did not show a noticeable green fluorescence in E. coli and S. aureus (Fig. 7a and b), and intense green fluorescent was observed in the positive controls treated with 60 µg/mL tetracycline (Fig. 7c and d). E. coli and S. aureus treated with ZnFe2O4 NPs (100 µg/mL) showed prominent fluorescent green, indicating membrane disruption (Fig. 7e and f). Previously, certain NPs, such as oleoyl-chitosan NPs, have been reported to affect membrane permeability through membrane damage in E. coli and S. aureus. Fei et al., also found that nano-sized silver NP clusters wrinkled and punctured the bacterial membrane, causing significant leakage of cytoplasmic content and eventually causing bacterial death. [76]. Our findings demonstrated that ZnFe2O4 NPs treatment can cause membrane disruption in both Gram-negative and Gram-positive strains, and can lead to bacterial death through cell membrane damage.

Fig. 7
figure7

Membrane permeability assay. Fluorescence images of E. coli and S. aureus showing the influx of FITC after treatment with zinc ferrite (ZnFe2O4) NPs and tetracycline (positive control). a Untreated E. coli (negative control). b Untreated S. aureus (negative control). c E. coli treated with tetracycline (positive control). d S. aureus treated with tetracycline (positive control). e E. coli treated with 100 µg/mL of ZnFe2O4 NPs. f S. aureus treated with 100 µg/mL of ZnFe2O4 NPs. Tetracycline and ZnFe2O4 NPs induced membrane damage to both Gram-positive and Gram-negative bacteria, resulted in the membrane permeability to the green fluorescent FITC dye. Scale bars show 100 µm

Effects of ZnFe2O4 NPs treatment on bacterial protein leakage

We then investigated whether the disruption of bacterial cell membrane by ZnFe2O4 NPs could lead to leakage of cytoplasmic materials (e.g., minerals, proteins, and genetic materials). Figure 8 shows the leaked protein concentrations of E. coli and S. aureus after ZnFe2O4 NPs treatment compared to positive and negative controls. The NP-treated groups showed protein leakage of 0.6 µg/mL and 0.7 µg/mL, respectively, in E. coli and S. aureus, which was ~ 3x and ~ 2.5x higher than untreated control. Similar results were observed for zinc oxide (ZnO) NPs, which caused protein leakage in Acinetobacter baumannii by damaging the bacterial cell membrane [77]. Silver NPs (AgO) are also reported to trigger membrane damage and protein leakage in both Gram-negative and Gram-positive microorganisms [78]. Despite the higher bacteriostatic and bactericidal effects of ZnFe2O4 NPs in Gram-positive strains, the protein leakage concentration by Gram-negative bacteria (E. coli) was higher than that of Gram-positive bacteria (S. aureus), which may be due to differences in the structure and chemical composition of the cell wall. The bacterial wall of Gram-negative bacteria is composed of a specific arrangement of lipid A, lipopolysaccharides and peptidoglycans less than 15 nm thick. However, Gram-positive bacteria contain mainly very thick peptidoglycans with a cell wall of ~ 80 nm, which acts as a boundary layer, protecting the large molecules such as protein to be easily leaked out after disruption of the cell membrane [79].

Fig. 8
figure8

Protein leakage assay. The concentration of protein detected in ZnFe2O4 NPs (100 µg/mL) treated E. coli and S. aureus after 8 h of treatment versus untreated bacteria as a negative control (NC). All experiments were done in triplicate, and the data are presented as mean ± SD. ****p ≤ 0.0001 was considered statistically significant

ROS generation after treatment with NPs

ROS production represents the oxidative stress of bacterial cells, which is one of the mechanisms of bacterial cell death by anti-microbial agents [80]. The adsorption of small nanomaterials on the cell surface can produce intracellular ROS leading to bacterial cell death. Therefore, we analyzed intracellular ROS production in E. coli and S. aureus treated with ZnFe2O4 NPs to analyze the bactericidal mechanism of ZnFe2O4 NPs. As shown in Fig. 9, the ROS production of the NP-treated groups was approximately 5 times higher than that of the untreated group (negative control). Interestingly, ROS production in NP-treated E. coli was ~ 2.5 times higher than that of the positive control, H2O2 treated E. coli. Previously, Dong et al. reported that the ROS generation through treatment with ZnFe2O4 NPs was sufficient to kill tumor cells [81]. In addition, a hybrid of ZnO/ZnFe2O4 can also produce ROS in bacterial cells, which is responsible for bacterial cell death [82]. Taken together, our results showed that ZnFe2O4 NPs can induce ROS production in both Gram-negative and Gram-positive bacteria.

Fig. 9
figure9

Reactive oxygen species (ROS) assay. Intracellular ROS production after 8 h of treatment with ZnFe2O4 NPs (100 µg/mL) in E. coli and S. aureus. Hydrogen peroxide (H2O2) treated cells were taken as a positive control (PC), and bacteria without treatment served as a negative control (NC). All experiments were performed in triplicates, and data are presented as mean ± SD. **p ≤ 0.01 and****p ≤ 0.0001 were considered as statistically significant

Enhanced wound shrinkage by ZnFe2O4 NPs

Complex wounds such as burns require the application of substances that promote wound healing as well as anti-bacterial properties. The in vitro scratch assay is used to understand the cell migration and proliferation during the wound healing process, and is a useful method for investigating the wound healing potential of drugs or nanoparticles [83]. This assay can conclusively reveal whether a specific compound or substance accelerates or slows down the rate of cell migration and proliferation [84]. In vitro scratch assay was performed to demonstrate the wound healing potential of ZnFe2O4 NPs at a biocompatible dose (100 µg/mL). As can be seen in Fig. 10a, improved cell migration and wound closure were observed in ZnFe2O4 NPs treated samples compared to the untreated control after 18 h and 36 h of treatment. In addition, significantly higher percent scratch shrinkage (66 %) was observed in NPs treated samples compared to the control (41 %) at 18 h post-treatment (Fig. 10b). Previously, bacterial nanocellulose/iron oxide (BCN/Fe3O4) nanofilms treatment showed improved HDF migration in in vitro scratch assay [83]. Mirzahosseinipour et al. also found that curcumin-Silica NPs improve HDF cell migration and proliferation [85]. The silver-incorporated cotton fabrics were also exhibited significant in vivo wound healing effect [86]. Similarly, Boomi et al. observed accelerated wound healing effect in diabetic BALB/c mice after topical application of gold nanoparticles (AuNPs) on the surface of wound [87]. The possible mechanisms of MNPs-induced wound-healing proposed include enhanced angiogenesis, modifying the membrane potential, preventing enzyme ATP synthase, and generating intracellular ROS which results in hampered energy metabolism and wound healing. To the best of our knowledge, this is the first study conducted to evaluate ZnFe2O4 NPs wound healing potential. Taken together, our research provided the basis for further wound healing applications of ZnFe2O4 NPs as well as their promising anti-bacterial effect.

Fig. 10
figure10

Scratch assay of NIH-3T3 fibroblast cells in the presence of ZnFe2O4 NPs (100 µg/mL). a Bright-field images of the negative control (untreated cells) and ZnFe2O4 NPs treated cells after 0, 18, and 36 h of incubation. b Percent (%) scratch shrinkage of ZnFe2O4 NPs treated cells versus the untreated control after 18 h. The experiments were performed in triplicates, and data are presented as mean ± SD. The data were analyzed using t-test, where **p ≤ 0.01 was considered statistically significant

Conclusions

ZnFe2O4 NPs synthesized by co-precipitation method are spherical in shape, show little agglomeration, have uniform elemental compositions, and possess all characteristic peaks of spinel ferrite NPs. The prepared ZnFe2O4 NPs presented excellent biocompatibility and hemocompatibility with HDFs and human RBCs and exhibited potent antimicrobial activity against both Gram-positive and Gram-negative microbial strains at biocompatible concentration. We also revealed the possible antimicrobial mechanisms that ZnFe2O4 NPs triggered bacterial cell death via membranes disruption, protein leakage, and ROS generation for the bactericidal efficacy. Furthermore, our NPs also exhibited excellent in vitro wound healing properties. This study showed that ZnFe2O4 NPs have promising antibacterial properties and desirable biocompatibility to promote wound healing. Hence, the optimized ZnFe2O4 NPs can be used as an alternative therapeutic agent against drug-resistance microbial pathogens and also as a bandage to enhance burn-wound healing in near future. In addition, future study is required to investigate short-term and long-term toxicity and wound-healing effect of ZnFe2O4 NPs in animal models.

Availability of data and materials

All the generated or analyzed data during this study are included in this manuscript.

References

  1. 1.

    Blair JM, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369–78.

    PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Saravanan M, Ramachandran B, Barabadi H. The prevalence and drug resistance pattern of extended spectrum β–lactamases (ESBLs) producing Enterobacteriaceae in Africa. Microb Pathog. 2018;114:180–92.

    PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Mohamed H. One year prevalence of critically ill burn wound bacterial infections in surgical ICU in Egypt: Retrospective study. Egyptian Journal of Anaesthesia. 2016;32(3):431–4.

    Article  Google Scholar 

  5. 5.

    Church D, et al. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–34.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Lachiewicz AM, et al. Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance. Clin Infect Dis. 2017;65(12):2130–6.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Cotter J, et al. Chemical parameters, antimicrobial activities, and tissue toxicity of 0.1 and 0.5 % sodium hypochlorite solutions. Antimicrob Agents Chemother. 1985;28(1):118–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Dobrucka R, Długaszewska J. Biosynthesis and antibacterial activity of ZnO nanoparticles using Trifolium pratense flower extract. Saudi J Biol Sci. 2016;23(4):517–23.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Qing Ya, et al. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int J Nanomed. 2018;13:3311–27.

    CAS  Article  Google Scholar 

  10. 10.

    Ahamed M, et al. Synthesis, characterization, and antimicrobial activity of copper oxide nanoparticles. J Nanomater. 2014;2014:637858.

    Article  CAS  Google Scholar 

  11. 11.

    Moradpoor H, et al. Optimisation of cobalt oxide nanoparticles synthesis as bactericidal agents. Open access Macedonian J Med Sci. 2019;7(17):2757–62.

    Article  Google Scholar 

  12. 12.

    Barabadi H. Nanobiotechnology: a promising scope of gold biotechnology. Cell Mol Biol. 2017;63(12):3–4.

    PubMed  Article  Google Scholar 

  13. 13.

    Haghniaz R, et al. Dextran stabilized lanthanum strontium manganese oxide nanoparticles for magnetic resonance imaging. RSC Adv. 2013;3(40):18489–97.

    CAS  Article  Google Scholar 

  14. 14.

    Barabadi H, et al. Emerging theranostic gold nanomaterials to combat lung cancer: a systematic review. J Cluster Sci. 2020;31(2):323–30.

    CAS  Article  Google Scholar 

  15. 15.

    Haghniaz R, Umrani RD, Paknikar KM. Hyperthermia mediated by dextran-coated La0.7Sr0.3MnO3 nanoparticles: in vivo studies. Int J Nanomed. 2016;11:1779–91.

    CAS  Google Scholar 

  16. 16.

    Horie M, et al. Association of the physical and chemical properties and the cytotoxicity of metal oxide nanoparticles: metal ion release, adsorption ability and specific surface area. Metallomics. 2012;4(4):350–60.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Djurišić AB, et al. Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental artefacts. Small. 2015;11(1):26–44.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Mihai MM, et al. Nanomaterials for wound healing and infection control. Materials (Basel Switzerland). 2019;12(13):2176.

    CAS  Article  Google Scholar 

  19. 19.

    Khatua A, et al. Phytosynthesis, characterization and fungicidal potential of emerging gold nanoparticles using Pongamia pinnata leave extract: a novel approach in nanoparticle synthesis. J Cluster Sci. 2020;31(1):125–31.

    CAS  Article  Google Scholar 

  20. 20.

    Coker VS, Nanoscience: Volume 1: Nanostructures through chemistry. Vol. 1. 2012: Royal Society of Chemistry.

  21. 21.

    Allahverdiyev AM, et al. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Exp Rev Anti-infect Ther. 2011;9(11):1035–52.

    CAS  Article  Google Scholar 

  22. 22.

    Rafienia M, Bigham A, Hassanzadeh-Tabrizi SA. Solvothermal synthesis of magnetic spinel ferrites. J Med Signals Sens. 2018;8(2):108–18.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Kefeni KK, et al. Spinel ferrite nanoparticles and nanocomposites for biomedical applications and their toxicity. Mater Sci Eng C. 2020;107:110314.

    CAS  Article  Google Scholar 

  24. 24.

    Hyder F, Hoque SM. Brain tumor diagnostics and therapeutics with superparamagnetic ferrite nanoparticles. Contrast Media Mol Imaging. 2017;2017:1–17.

    Article  CAS  Google Scholar 

  25. 25.

    Kmita A, et al. One-step synthesis of long term stable superparamagnetic colloid of zinc ferrite nanorods in water. Materials. 2019;12(7):1048.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  26. 26.

    Borade RM, et al. Spinel zinc ferrite nanoparticles: an active nanocatalyst for microwave irradiated solvent free synthesis of chalcones. Materials Res Expr. 2020;7(1):016116.

    CAS  Article  Google Scholar 

  27. 27.

    Somvanshi SB, et al. Hydrophobic to hydrophilic surface transformation of nano-scale zinc ferrite via oleic acid coating: magnetic hyperthermia study towards biomedical applications. Ceram Int. 2020;46(6):7642–53.

    CAS  Article  Google Scholar 

  28. 28.

    Cruz IF, et al., Chap. 3 - Multifunctional Ferrite Nanoparticles: From Current Trends Toward the Future, in Magnetic Nanostructured Materials, A.A. El-Gendy, J.M. Barandiarán, and R.L. Hadimani, Editors. 2018, Elsevier. p. 59–116.

  29. 29.

    Han L, et al. Synthesis of ZnFe2O4 nanoplates by succinic acid-assisted hydrothermal route and their photocatalytic degradation of rhodamine B under visible light. J Environ Chem Eng. 2014;2(1):123–30.

    CAS  Article  Google Scholar 

  30. 30.

    Ebrahimi M, et al. Magnetic properties of zinc ferrite nanoparticles synthesized by coprecipitation method. J Supercond Nov Magn. 2014;27(6):1587–92.

    CAS  Article  Google Scholar 

  31. 31.

    Haghniaz R, Umrani RD, Paknikar KM. Temperature-dependent and time-dependent effects of hyperthermia mediated by dextran-coated La0.7Sr0.3MnO3: in vitro studies. Int J Nanomed. 2015;10:1609–23.

    CAS  Article  Google Scholar 

  32. 32.

    Deepracha S, Vibulyaseak K, Ogawa M, Chap. 2.1 - Complexation of TiO2 with clays and clay minerals for hierarchically designed functional hybrids. In: Advanced supramolecular Nanoarchitectonics, K. Ariga and M. Aono, eds. 2019, William Andrew Publishing. p. 125–150.

  33. 33.

    Sheikhi A, et al. Modular microporous hydrogels formed from microgel beads with orthogonal thermo-chemical responsivity: microfluidic fabrication and characterization. MethodsX. 2019;6:1747–52.

    PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    ASTM E2524-08(2013), S.T.M.f.A.o.H.P.o.N., International ASTM. West Conshohocken, PA, 2013, www.astm.org.

  35. 35.

    El-Batal AI, et al. Response surface methodology optimization of melanin production by Streptomyces cyaneus and synthesis of copper oxide nanoparticles using Gamma Radiation. J Cluster Sci. 2016;28:1083–112.

    Article  CAS  Google Scholar 

  36. 36.

    Al-Aali K. Microbial profile of burn wound infections in burn patients, Taif, Saudi Arabia. Arch Clin Microbiol. 2016;7(2):1–9.

    Google Scholar 

  37. 37.

    Weinstein RA, Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003;37(4):543–50.

    Article  Google Scholar 

  38. 38.

    Huang W, et al. Chemical analysis and in vitro antimicrobial effects and mechanism of action of Trachyspermum copticum essential oil against Escherichia coli. Asian Pacific Journal of Tropical Medicine. 2017;10(7):663–9.

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Carlos Ruiz-Ruiz J, et al. Antibacterial activity of proteins extracted from the pulp of wild edible fruit of Bromelia pinguin L. Int J Food Prop. 2017;20(1):220–30.

    CAS  Article  Google Scholar 

  40. 40.

    Dadi R, et al. Antibacterial activity of ZnO and CuO nanoparticles against gram positive and gram negative strains. Materials Science Engineering: C. 2019;104:109968.

    CAS  Article  Google Scholar 

  41. 41.

    Akbar A, et al. Synthesis and antimicrobial activity of zinc oxide nanoparticles against foodborne pathogens Salmonella typhimurium and Staphylococcus aureus. Biocatal Agric Biotechnol. 2019;17:36–42.

    Article  Google Scholar 

  42. 42.

    Gopinath V, et al. Biogenic synthesis, characterization of antibacterial silver nanoparticles and its cell cytotoxicity. Arab J Chem. 2017;10(8):1107–17.

    CAS  Article  Google Scholar 

  43. 43.

    Saritha K, et al. Mechanism of antibacterial action of the alcoholic extracts of Hemidesmus indicus (L.) R. Br. ex Schult, Leucas aspera (Wild.), Plumbago zeylanica L., and Tridax procumbens (L.) R. Br. ex Schult. Front Microbiol. 2015;6:577.

    PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Zhang L, et al. Antibacterial activity and mode of action of Mentha arvensis ethanol extract against multidrug-resistant Acinetobacter baumannii. Trop J Pharm Res. 2015;14(11):2099.

    Article  CAS  Google Scholar 

  45. 45.

    Navarro Gallon SM, et al. Characterization and study of the antibacterial mechanisms of silver nanoparticles prepared with microalgal exopolysaccharides. Mater Sci Eng C Mater Biol Appl. 2019;99:685–95.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  46. 46.

    Felder M, et al. Impaired wound healing of alveolar lung epithelial cells in a breathing lung-on-a-chip. Front Bioeng Biotechnol. 2019;7:3.

    PubMed  PubMed Central  Article  Google Scholar 

  47. 47.

    Saravanan M, et al. Chapter Eleven - Emerging plant-based anti-cancer green nanomaterials in present scenario. In: Verma SK, Das AK, editors., et al., Comprehensive Analytical Chemistry. Elsevier: New York; 2019. p. 291–318.

    Google Scholar 

  48. 48.

    Permien S, et al. What happens structurally and electronically during the li conversion reaction of CoFe2O4 nanoparticles: an operando XAS and XRD investigation. Chem Mater. 2016;28(2):434–44.

    CAS  Article  Google Scholar 

  49. 49.

    Masoudpanah SM, et al. Structure and magnetic properties of La substituted ZnFe2O4 nanoparticles synthesized by sol–gel autocombustion method. J Magn Magn Mater. 2014;370:122–6.

    CAS  Article  Google Scholar 

  50. 50.

    Wang Y, et al. Mercury bioaccumulation in fish in an artificial lake used to carry out cage culture. J Environ Sci. 2019;78:352–9.

    Article  Google Scholar 

  51. 51.

    Abbas M, Parvatheeswara Rao B, Kim C. Shape and size-controlled synthesis of Ni Zn ferrite nanoparticles by two different routes. Mater Chem Phys. 2014;147(3):443–51.

    CAS  Article  Google Scholar 

  52. 52.

    Rameshbabu R, et al. Synthesis and study of structural, morphological and magnetic properties of ZnFe2O4 nanoparticles. J Supercond Nov Magn. 2014;27(6):1499–502.

    CAS  Article  Google Scholar 

  53. 53.

    Nag S, Das D, Mukherjee S, Rare earth (Er3+) doped nickel zinc ferrite: Additional effects in structural and dielectric properties. AIP Conference Proceedings, 2019. 2142(1): p. 040003.

  54. 54.

    Rehman S, et al. Antibacterial and Antifungal Activity of Novel Synthesized Neodymium-Substituted Cobalt Ferrite Nanoparticles for Biomedical Application. Processes. 2019;7(10):714.

    CAS  Article  Google Scholar 

  55. 55.

    Barabadi H, et al. Emerging theranostic silver and gold nanomaterials to combat prostate cancer: a systematic review. J Cluster Sci. 2019;30(6):1375–82.

    CAS  Article  Google Scholar 

  56. 56.

    Bankier C, et al. Synergistic antibacterial effects of metallic nanoparticle combinations. Sci Rep. 2019;9(1):16074.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  57. 57.

    Inam M, et al. Size and shape affects the antimicrobial activity of quaternized nanoparticles. J Polym Sci Part A: Polym Chem. 2019;57(3):255–9.

    CAS  Article  Google Scholar 

  58. 58.

    Borade RM, et al. Spinel zinc ferrite nanoparticles: an active nanocatalyst for microwave irradiated solvent free synthesis of chalcones. Mater Res Express. 2020;7(1):016116.

    CAS  Article  Google Scholar 

  59. 59.

    Maurer-Jones MA, et al. Toxicity of therapeutic nanoparticles. Nanomedicine (Lond). 2009;4(2):219–41.

    CAS  Article  Google Scholar 

  60. 60.

    Iacovita C, et al. Hyperthermia, cytotoxicity, and cellular uptake properties of manganese and zinc ferrite magnetic nanoparticles synthesized by a polyol-mediated process. Nanomaterials. 2019;9(10):1489.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  61. 61.

    Barabadi H, et al. Emerging theranostic gold nanomaterials to combat colorectal cancer: a systematic review. J Cluster Sci. 2020;31(4):651–8.

    CAS  Article  Google Scholar 

  62. 62.

    Vahidi H, Barabadi H, Saravanan M. Emerging selenium nanoparticles to combat cancer: a systematic review. J Cluster Sci. 2020;31(2):301–9.

    CAS  Article  Google Scholar 

  63. 63.

    Barabadi H, et al. Emerging theranostic silver nanomaterials to combat colorectal cancer: a systematic review. J Cluster Sci. 2020;31(2):311–21.

    CAS  Article  Google Scholar 

  64. 64.

    Mendonca R, Silveira AA, Conran N. Red cell DAMPs and inflammation. Inflamm Res. 2016;65(9):665–78.

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Manaargadoo-Catin M, et al. Hemolysis by surfactants—a review. Adv Coll Interf Sci. 2016;228:1–16.

    CAS  Article  Google Scholar 

  66. 66.

    Mohamed HEA, et al. Bio-redox potential of Hyphaene thebaica in bio-fabrication of ultrafine maghemite phase iron oxide nanoparticles (Fe2O3 NPs) for therapeutic applications. Mater Sci Eng C. 2020;112:110890.

    CAS  Article  Google Scholar 

  67. 67.

    Martínez-Rodríguez NL, Tavárez S, González-Sánchez ZI. In vitro toxicity assessment of zinc and nickel ferrite nanoparticles in human erythrocytes and peripheral blood mononuclear cell. Toxicol In Vitro. 2019;57:54–61.

    PubMed  Article  CAS  Google Scholar 

  68. 68.

    Madhukara Naik M, et al. Green synthesis of zinc ferrite nanoparticles in Limonia acidissima juice: characterization and their application as photocatalytic and antibacterial activities. Microchem J. 2019;146:1227–35.

    CAS  Article  Google Scholar 

  69. 69.

    Mandal S, et al. Photocatalytic and antimicrobial activities of zinc ferrite nanoparticles synthesized through soft chemical route: A magnetically recyclable catalyst for water/wastewater treatment. J Environ Chem Eng. 2016;4(3):2706–12.

    CAS  Article  Google Scholar 

  70. 70.

    Jiang L, et al. Construction of an efficient nonleaching graphene nanocomposites with enhanced contact antibacterial performance. Chem Eng J. 2020;382:122906.

    CAS  Article  Google Scholar 

  71. 71.

    Stiefel P, et al. Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide. BMC Microbiol. 2015;15(1):36.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  72. 72.

    Manyasree D, Kiranmayi P, Venkata RK. Characterization and antibacterial activity of ZnO nanoparticles synthesized by co-precipitation method. International Journal of Applied Pharmaceutics. 2018;10(6):224–8.

    CAS  Article  Google Scholar 

  73. 73.

    Surendra BS, et al. Jatropha extract mediated synthesis of ZnFe2O4 nanopowder: Excellent performance as an electrochemical sensor, UV photocatalyst and an antibacterial activity. Chem Phys Lett. 2020;739:136980.

    CAS  Article  Google Scholar 

  74. 74.

    Halder S, et al. Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents. SpringerPlus. 2015;4(1):672.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  75. 75.

    Huang F, et al. Membrane damage mechanism contributes to inhibition of trans-cinnamaldehyde on Penicillium italicum using Surface-Enhanced Raman Spectroscopy (SERS). Sci Rep. 2019;9(1):490.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  76. 76.

    Fei X, et al. Antimicrobial peptide-templated silver nanoclusters with membrane activity for enhanced bacterial killing. J Nanosci Nanotechnol. 2020;20(3):1425–33.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  77. 77.

    Tiwari V, et al. Mechanism of anti-bacterial activity of zinc oxide nanoparticle against carbapenem-resistant Acinetobacter baumannii. Frontiers in microbiology. 2018;9:1218.

    PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    Dakal TC, et al. Mechanistic basis of antimicrobial actions of silver Nanoparticles. Front Microbiol. 2016;7:1831–1.

    PubMed  PubMed Central  Article  Google Scholar 

  79. 79.

    Lee PC, et al. Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria. Chem Biol Drug design. 2019;94(2):1537–44.

    CAS  Google Scholar 

  80. 80.

    Muthukumar K, et al. Solvothermal synthesis of magnetic copper ferrite nano sheet and its antimicrobial studies. Mater Chem Phys. 2018;209:172–9.

    CAS  Article  Google Scholar 

  81. 81.

    Dong S, et al. Upconversion-mediated ZnFe2O4 nanoplatform for NIR-enhanced chemodynamic and photodynamic therapy. Chem Sci. 2019;10(15):4259–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  82. 82.

    Tong G, et al. Enhanced reactive oxygen species (ROS) yields and antibacterial activity of spongy ZnO/ZnFe2O4 hybrid micro-hexahedra selectively synthesized through a versatile glucose-engineered co-precipitation/annealing process. J Mater Chem B. 2013;1(20):2647–57.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  83. 83.

    Moniri M, et al. Molecular study of wound healing after using biosynthesized BNC/Fe(3)O(4) nanocomposites assisted with a bioinformatics approach. Int J Nanomedicine. 2018;13:2955–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  84. 84.

    Pinto BI, et al. In vitro scratch assay to demonstrate effects of arsenic on skin cell migration. J Visual Exp. 2019;144:e58838.

    Google Scholar 

  85. 85.

    Mirzahosseinipour M, et al. Antimicrobial photodynamic and wound healing activity of curcumin encapsulated in silica nanoparticles. Photodiagn Photodyn Ther. 2020;29:101639.

    CAS  Article  Google Scholar 

  86. 86.

    Pannerselvam B, et al. In vitro cytotoxicity and antibacterial activity of optimized silver nanoparticles against wound infectious bacteria and their morphological studies. J Cluster Sci. 2020;1:1–14.

    Google Scholar 

  87. 87.

    Boomi P, et al. Phyto-Engineered Gold Nanoparticles (AuNPs) with potential antibacterial, antioxidant, and wound healing activities Under in vitro and in vivo conditions. Int J Nanomed. 2020;15:7553–68.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Nasim Annabi for donating S. aureus bacterial culture, and Dr. Ehsan Shirzaei Sani for his advice on antimicrobial tests.

Funding

This work was supported by higher education commissions of Pakistan for international research support initiative program.

Author information

Affiliations

Authors

Contributions

RH and AR conducted the experiments, analyzed the data, and wrote this paper. FV contributed to scratch assay experiments. TK, RK, and ARK assisted in the data analysis for the characterization of the nanoparticles. HM and JI assisted in the editing of the figures. HK and FW supervised the work and revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Han-Jun Kim or Fazli Wahid.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors agreed to submit this study.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Haghniaz, R., Rabbani, A., Vajhadin, F. et al. Anti‐bacterial and wound healing‐promoting effects of zinc ferrite nanoparticles. J Nanobiotechnol 19, 38 (2021). https://doi.org/10.1186/s12951-021-00776-w

Download citation

Keywords

  • Nanoparticles
  • Spinel ferrites
  • Zinc ferrites
  • Antimicrobial activity
  • Wound healing
  • Biocompatibility
  • Hemocompatibility
  • Antibiotics